Haemonetics Corp. (HAE) Tops Q1 EPS by 2c

Haemonetics Corp. (NYSE: HAE) reported Q1 EPS of $0.38, $0.02 better than the analyst estimate of $0.36. Revenue for the quarter came in at $224.49 million versus the consensus estimate of $215.85 million.

For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Bernstein SocGen on Performance Food Group (PFGC): 'Not the quarter we were hoping for, but LT story intact'
• DA Davidson Reiterates Neutral Rating on Nebius Group (NBIS)